CHARACTERISTICS OF UPPER GASTROINTESTINAL BLEEDING IN CIRRHOTIC PATIENTS

2018 ◽  
Author(s):  
F Errabie ◽  
A Elmekkaoui ◽  
W Khannoussi ◽  
G Kharrasse ◽  
Z Ismaili
Keyword(s):  
Gastrointestinal Bleeding ◽  
Upper Gastrointestinal Bleeding ◽  
Cirrhotic Patients ◽  
Upper Gastrointestinal

scholarly journals Isoleucine infusion during “simulated” upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patients

Hepatology ◽  
2007 ◽  
Vol 45 (3) ◽  
pp. 560-568 ◽  
Author(s):  
Steven W. M. Olde Damink ◽  
Rajiv Jalan ◽  
Nicolaas E. P. Deutz ◽  
Cornelis H. C. Dejong ◽  
Doris N. Redhead ◽  
...  
Keyword(s):  
Protein Synthesis ◽  
Gastrointestinal Bleeding ◽  
Upper Gastrointestinal Bleeding ◽  
Muscle Protein ◽  
Muscle Protein Synthesis ◽  
Cirrhotic Patients ◽  
Upper Gastrointestinal

scholarly journals Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding

2010 ◽  
Author(s):  
Norberto C Chavez-Tapia ◽  
Tonatiuh Barrientos-Gutierrez ◽  
Felix I Tellez-Avila ◽  
Karla Soares-Weiser ◽  
Misael Uribe
Keyword(s):  
Gastrointestinal Bleeding ◽  
Antibiotic Prophylaxis ◽  
Upper Gastrointestinal Bleeding ◽  
Cirrhotic Patients ◽  
Upper Gastrointestinal

scholarly journals Effect of terlipressin on renal function in cirrhotic patients with acute upper gastrointestinal bleeding

2020 ◽  
Vol 8 (6) ◽  
pp. 340-340 ◽  
Author(s):  
Jingqiao Zhang ◽  
Jie Liu ◽  
Yunhai Wu ◽  
Fernando Gomes Romeiro ◽  
Giovanni Battista Levi Sandri ◽  
...  
Keyword(s):  
Renal Function ◽  
Gastrointestinal Bleeding ◽  
Upper Gastrointestinal Bleeding ◽  
Acute Upper Gastrointestinal Bleeding ◽  
Cirrhotic Patients ◽  
Upper Gastrointestinal

scholarly journals Prognostic Value of AIMS65 Score in Cirrhotic Patients with Upper Gastrointestinal Bleeding

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Vinaya Gaduputi ◽  
Molham Abdulsamad ◽  
Hassan Tariq ◽  
Ahmed Rafeeq ◽  
Naeem Abbas ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Gastrointestinal Bleeding ◽  
Prognostic Value ◽  
Upper Gastrointestinal Bleeding ◽  
Laboratory Features ◽  
Cirrhotic Patients ◽  
Rockall Score ◽  
Time Of Admission ◽  
Upper Gastrointestinal ◽  
Length Of Hospitalization

Introduction. Unlike Rockall scoring system, AIMS65 is based only on clinical and laboratory features. In this study we investigated the correlation between the AIMS65 score and Endoscopic Rockall score, in cirrhotic and noncirrhotic patients.Methods. This is a retrospective study of patients admitted with overt UGIB and undergoing esophagogastroduodenoscopy (EGD). AIMS65 and Rockall scores were calculated at the time of admission. We investigated the correlation between both scores along with stigmata of bleed seen on endoscopy.Results. A total of 1255 patients were studied. 152 patients were cirrhotic while 1103 patients were noncirrhotic. There was significant correlation between AIMS65 and Total Rockall scores in patients of both groups. There was significant correlation between AIMS65 score and Endoscopic Rockall score in noncirrhotics but not cirrhotics. AIMS65 scores in both cirrhotic and noncirrhotic groups were significantly higher in patients who died from UGIB than in patients who did not.Conclusion. We observed statistically significant correlation between AIMS65 score and length of hospitalization and mortality in noncirrhotic patients. We found that AIMS65 score paralleled the endoscopic grading of lesion causing UGIB in noncirrhotics. AIMS65 score correlated only with mortality but not the length of hospitalization or endoscopic stigmata of bleed in cirrhotics.

scholarly journals No Benefit of Hemostatic Drugs on Acute Upper Gastrointestinal Bleeding in Cirrhosis

2020 ◽  
Vol 2020 ◽  
pp. 1-11
Author(s):  
Yang An ◽  
Zhaohui Bai ◽  
Xiangbo Xu ◽  
Xiaozhong Guo ◽  
Fernando Gomes Romeiro ◽  
...  
Keyword(s):  
Gastrointestinal Bleeding ◽  
Hospital Mortality ◽  
Upper Gastrointestinal Bleeding ◽  
Meld Score ◽  
Drug Group ◽  
Red Blood Cell Transfusion ◽  
Acute Upper Gastrointestinal Bleeding ◽  
Rebleeding Rate ◽  
Cirrhotic Patients ◽  
Upper Gastrointestinal

Background and Aims. Acute upper gastrointestinal bleeding (AUGIB) is one of the most life-threatening emergency conditions. Hemostatic drugs are often prescribed to control AUGIB in clinical practice but have not been recommended by major guidelines and consensus. The aim of this study was to investigate the therapeutic effect of hemostatic drugs on AUGIB in cirrhosis. Methods. All cirrhotic patients with AUGIB who were admitted to our hospital from January 2010 to June 2014 were retrospectively included. Patients were divided into hemostatic drugs and no hemostatic drug groups. A 1 : 1 propensity score matching (PSM) analysis was performed by adjusting age, gender, etiology of liver disease, Child-Pugh score, MELD score, hematemesis, red blood cell transfusion, vasoactive drugs, antibiotics, proton pump inhibitors, and endoscopic variceal therapy. Primary outcomes included 5-day rebleeding and in-hospital mortality. Results. Overall, 982 cirrhotic patients with AUGIB were included (870 in hemostatic drugs group and 112 in no hemostatic drug group). In overall analyses, hemostatic drugs group had a significantly higher 5-day rebleeding rate (18.10% versus 5.40%, P=0.001) than no hemostatic drug group; in-hospital mortality was not significantly different between them (7.10% versus 4.50%, P=0.293). In PSM analyses, 172 patients were included (86 patients in each group). Hemostatic drugs group still had a significantly higher 5-day rebleeding rate (15.10% versus 5.80%, P=0.046); in-hospital mortality remained not significantly different (7.00% versus 3.50%, P=0.304) between them. Statistical results remained in PSM analyses according to the type of hemostatic drugs. Conclusions. The use of hemostatic drugs did not improve the in-hospital outcomes of cirrhotic patients with AUGIB.

Sign in / Sign up

Export Citation Format

Share Document